Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma.
Nicholas J HornsteinMohammad A ZeineddineBetul Beyza GunesAndrew J PellattMark KnaflHaifeng ZhuAnneleis F WillettAbdelrahman M G YousefSuyu LiuRyan SunP Andrew FutrealScott E WoodmanMelissa W TaggartMichael James OvermanDaniel M HalperinKanwal P S RaghavJohn Paul ShenPublished in: Cancer research communications (2024)
AA remains an orphan disease with limited systemic therapy options for patients who are not candidates for surgical resection. These data suggest activity from combined VEGF and PD-L1 inhibition that warrants further study.